Vanguard Group Inc Agile Therapeutics Inc Transaction History

Vanguard Group Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.18 - $15.25 $8,539 - $723,475	47,441 Added 161.26%	76,860 $17,000
Q3 2022 Nov 14, 2022	SELL	$0.28 - $14.85 $194 - $10,305	-694 Reduced 2.3%	29,419 $9,000
Q2 2022 Aug 12, 2022	BUY	$1.09 - $8.24 $32,823 - $248,131	30,113 New	30,113 $35,000

Ticker AGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 39,023,000
Description
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line exte...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.